{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-258662","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2025-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.793946+00:00","generated_at":"2026-05-17T01:13:56.177778+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Edwards Lifesciences CFO Scott Ullem to step down by mid-2026; successor search underway","bullets":["CFO Scott Ullem informed company on Oct. 30, 2025 of decision to transition by mid-2026.","Company initiating selection process to appoint a new CFO; Ullem will serve in advisory role after appointment.","Plan described as a planned transition to ensure continuity and smooth handoff."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-258662","json":"https://secwatch.observer/filing/0001193125-25-258662.json","markdown":"https://secwatch.observer/filing/0001193125-25-258662.md","text":"https://secwatch.observer/filing/0001193125-25-258662.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000119312525258662/0001193125-25-258662-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000119312525258662/d50813d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:13:56.177778+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}